Skip to content
Screener

Other geography segments

DK
$1.26M

Similar metrics at other companies

Staar Surgical logo
STAAUS — Non-Current Assets
$109.8M+36.4%
Napco Security Technologies logo
NSSCUS — Non-Current Assets
$5.73M
JHG
JHGUS — Non-Current Assets
$2.17B+1.2%
Oracle logo
ORCLUS — Non-Current Assets
$102.72B+126%
NTS
NTSKUS — Non-Current Assets
$67.39M
Photronics logo
PLABUS — Non-Current Assets
$200.82M+38.8%

Other financials

Income statement

See full
Operating income-$26.1M-62.4%
Net income-$24.2M-97.8%
EPS (diluted)-$0.80+93.8%

Balance sheet

See full
Cash & equivalents$237.4M
Total debt$1.0M
Total equity$454.3M+421%
Total assets$467.8M

Cash flow

See full
Operating cash flow-$22.6M-47.6%
CapEx$23.0K
Free cash flow-$22.7M-47.8%

Valuation

See full
Market cap$2.32B+108%
Enterprise value$2.08B

Returns & leverage

See full
Return on equity-45.7%
Debt / equity
Current ratio35.8×

Where this comes from

Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-344533
Line itemAs of / June 30, 2026As of / December 31, 2025
United States of America$234$461
Denmark1,2631,240
$1,497$1,701

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Hemab Therapeutics Holdings, Inc.'s US — non-current assets?
Hemab Therapeutics Holdings, Inc. (COAG) reported US — non-current assets of $234K in Q2 2026.
What does US — non-current assets mean?
This metric represents the total value of long-term assets held by the company within the United States geographic segment. These assets typically include property, plant, and equipment, intangible assets, and long-term investments that are expected to provide economic benefits beyond the current fiscal year. It serves as a measure of the company's long-term capital investment and infrastructure footprint within the domestic market.

Ask your AI about Hemab Therapeutics Holdings, Inc.'s us — non-current assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude